WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced securing an exclusive license from Louisiana State University Health Sciences Center at Shreveport, LA for intellectual property and know-how for treating chronic inflammatory diseases and organ rejection caused by transplantation mediated organ stress.
